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Abstract 
Introduction: Approximate entropy (ApEn) is a widely imposed metric to evaluate a chaotic 
response and irregularities of RR-intervals from an electrocardiogram. Yet, the technique is 
problematic due to the accurate choice of the tolerance (r) and embedding dimension (M). We 
prescribed the metric to evaluate these responses in subjects exhibiting symptoms of chronic 
obstructive pulmonary disease (COPD) and we strived to overcome this disadvantage by 
applying different groupings to detect the optimal. 
Methods: We examined 38 subjects split equally: COPD and control. To evaluate autonomic 
modulation the heart rate was measured beat-by-beat for 30 min in a supine position without 
any physical, sensory, or pharmacological stimuli. In the time-series obtained the ApEn was 
then applied with set values for tolerance, r and embedding dimension, M. Then, the differences 
between the two groups and their effect size by two measures (Cohen’s ds and Hedges’s gs) were 
computed. 
Results: The highest value of statistical significance accomplished for any effect size statistical 
combinations undertaken was -1.13 for Cohen’s ds, and -1.10 for Hedges’s gs with embedding 
dimension, M = 2 and tolerance, r = 0.1. 
Conclusion: ApEn was capable of optimally identifying the decrease in chaotic response in 
COPD. The optimal combination of r and M for this were 0.1 and 2, respectively. Despite this, 
ApEn is a relatively unpredictable mathematical marker and the use of other techniques to 
evaluate a healthy or pathological condition is encouraged. 
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RR-interval rhythm, obtained via an electrocardiographic trace, can deviate in an uneven and often chaotic manner 
[1–4]. Computational signal processing of physiological data has stimulated academics to investigate this area of 
research [5, 6]. Heart rate variability (HRV) is an easy, dependable and relatively cheap technique to monitor the 
autonomic nervous system (ANS) and, a useful technique for judging healthy and pathological states [7–9]. 
Alternative methods to monitor the ANS are either insensitive for example, sympathetic skin response [10, 11] or too 
complicated and overpriced such as, quantitative pupillography [12]. Chaotic performances in biological and medical 
dynamical systems may specify normal physiological status but, loss of chaotic tendencies could be an abnormal and 
pathological marker [13]. 
HRV can be evaluated by means of approximate entropy (ApEn) [14]. The benefits of ApEn include low 
computational processor demand and it can adapt to short time-series (RR < 50). Accordingly, it could be a candidate 
metric to be enforced online in clinics or critical care units, where processing speed is imperative. Additionally, it can 
decipher statistics accurately even in the presence of considerable signal noise. 
Regrettably, it has a key disadvantage that it is excessively dependent on parameter choices for its tolerance, r and 
embedding dimension, M. So, ApEn results are unpredictable and difficult to interpret, when compared to the other 
techniques, such as the chaotic global procedures [2, 13, 15, 16]. 
In this context, we enforced different combinations for r and M in subjects exhibiting chronic obstructive pulmonary 
disease (COPD) [17–19] symptoms and those without with the objective of locating the most statistically significant 
ones to categorize the two groups and develop an application of ApEn which can separate their datasets. This is 
important to offer a useful clinical and analytical tool for clinicians and other health professionals to make necessary 
decisions. 
Methods: Patient Selection and Assessment 
A total of 38 subjects were studied. 19 exhibited the clinical symptoms of COPD and 19 were considered normal and 
designated controls in the study. Data was logged with a controlled laboratory temperature between 21°C and 24°C, 
and humidity between 50% and 60%. Subjects were instructed to avoid consumption of alcoholic beverages and 
caffeinated drinks or heavy foodstuffs for 24 h prior to the assessments. The experimental procedures were completed 
between 8:00 am and 11:00 am to minimalize circadian rhythm interferences. All actions needed for the data collection 
were described to the individuals, and the subjects were instructed to continue at rest and to avoid speaking throughout 
the experiment [20]. 
Following the preliminary evaluation, the heart monitor strap was placed on the subject’s thorax at the level of the 
distal third of the sternum. The HR equipment (Polar S810i monitor, Polar Electro OY, Kempele, Finland) was 
attached to the wrist [9, 21]. This apparatus had been formerly validated for HRV analysis. The subjects were supinely 
positioned and stationary with 30 min of spontaneous breathing. 
To authenticate the COPD diagnosis, the forced vital capacity test was performed [22] pre-bronchodilator to post-
bronchodilator [23, 24] via a portable spirometer (MIR, Spirobank version 3.6, Italy) linked to a computer using 
WinspiroPRO 1.1.6 software. The forced expiratory volume in one second (FEV1) should be ≥80% of the projected 
normal values with a FEV1/FVC (forced vital capacity) namely < 70%, which is considered the bronchial obstruction 
threshold [23]. 





HRV was logged throughout the monitoring process with a sampling rate of 1 kHz. Precisely, 1000 RR intervals were 
selected for analysis after digital and manual filtering for the elimination of untimely ectopic beats and artefacts. Only 
series with > 95% sinus rhythm were considered in the final study. 
Mathematical Assessment 
Approximate entropy 
Entropy based approaches are frequently required for physiological data and signal analysis [25–28]. ApEn [26, 28–
30], is a metric that assesses the level of regularity and unpredictability of time-series fluctuations. ApEn is the 
logarithmic ratio of component-wise matching sequences from the signal length, N. Further constraints include r for 
tolerance and M for the embedding dimension. A value of zero for ApEn would indicate a totally predictable series. 
ApEn rises with increasing chaotic response and irregularities. ApEn is described algebraically in the Kubios HRV® 
analysis manual [31]. 
First a set of length m vectors ju  is formed: 
1 1= ( , ,........., ), = 1,2,... 1j j j j mu RR RR RR j N m+ + − − +  
The distance between these vectors is defined as the maximum absolute difference between corresponding elements, 
( , ) = max{ | = 0,...., 1}j k j n k nd u u RR RR n m+ +− −  
Next, for each ju  the relative number of vectors ku  for which ( ),j kd u u r„  is considered. This index is denoted 
with ( )mjC r  and can be written in the form 
nbrof { | ( , ) }











( )mjC r  is at least ( )1 / 1N m− +  since ju  is likewise included in the count.  
Then, take the natural logarithm of each ( )mjC r  and average over j to yield. 
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Lastly, ApEn is defined as: 1ApEn( , , ) = ( ) ( ).m mm r N r r+ −  
For analysis, 25 groups of values were required with r ranging initially from 0.1→0.5 in intervals of 0.1 and, M as 
1→5 in intervals of 1. 
Effect sizes 
We assessed two effect sizes [32–34] to consider the datasets significances. We excluded any assessments of normality 
[35–37] usually followed by the application of the one-way analysis of variance [38] (ANOVA1), or Kruskal-Wallis 
tests [39]. These two statistical approaches are unable to discriminate sufficiently between the small changes in 
significance that are apparent here. 
Cohen’s ds is the principal subcategory. It refers to the standardized mean difference between two groups of 
independent observations for a suitable sample [40]. It is formulated on the sample means and gives a biased 





approximation of the population effect size, with samples < 20 [41]. Its value may vary from zero to infinity and can 
be positive or negative, dependent on the direction of increase or decrease between the values. 
In the statistical formula for Cohen’s ds, the numerator is the variation between the means of two groups of 
observations. The denominator is the pooled standard deviation. These variations are squared to avoid the positive and 
negative values cancelling each other out. They are summed, then divided by the number of observations minus one 
for bias in the estimate of the population variance. Then, the square root is performed. 
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As specified above, a discrepancy with effect sizes is if they are corrected for bias or not [42]. Accordingly, Cohen’s 
ds is often represented as the uncorrected effect size. Hedges’s gs is the corrected effect size and as such unbiased. 
The change between Cohen’s ds and Hedges’s gs is small particularly in sample sizes > 20 [43]. In this study we have 
a sample size of 19. 
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For Cohen’s ds and Hedges’s gs the extents are denoted as 0.01 > very small effect; 0.20 > small effect; 0.50 > medium 
effect; 0.80 > large effect; 1.20 > very large effect; based on the standards from Cohen and Sawilowsky [44, 45]. 
Results 
ApEn for controls and COPD subjects with values for tolerance, r (0.1→0.5 in intervals of 0.1) and embedding 
dimension, M (1→5 in intervals of 1) are illustrated (Table 1). At M = 1 and M = 2, all of the values for r are appropriate 
as COPD has lesser chaotic response than the control and so negative effect sizes throughout. Effect size values for 
these parameters are between -0.40 and -1.13 (small to large effect sizes). These are significant and physiologically 
suitable. At that point, as M increases additional values for r become inappropriate exhibiting positive effect sizes. 
For M = 3 and r = 0.1, this is non-valid and with M = 4 and M = 5 the tolerances of r = 0.1 and r = 0.2 are likewise 
invalid and so dismissed. For M = 3 and M = 4 when the values are physiologically valid at different levels of tolerance 
the effect sizes are between -0.53 and -0.83 (medium to large effect sizes). To conclude, at M = 5 for tolerances, r of 
r = 0.3 to r = 0.5, the effect sizes range from -0.34 to -0.99 (small to large effect sizes). 
We now inspect zones of greatest significance by their effect sizes in finer detail (Figure 1 and 2) (Table 2). From 
table 1, the greatest significance was achieved at M = 2 and r = 0.1. So, we assess this zone of values more intensively. 
Once more, we fix values for M and r. There are values for tolerance, r (0.01→0.25 in intervals of 0.01) and embedding 
dimension, M (1→5 in intervals of 1). For the combinations of M and r we determine that the optimal embedding 
dimension, M = 2 attains greatest significance when tolerance, r = 0.1. This then corresponds to an effect size of -1.13 
for Cohen’s ds (large effect size) and -1.10 for Hedges’s gs (large effect size). These are the highest values of statistical 
significance by effect sizes attained for any of the combinations offered (Figure 2 and Table 2). They are unchanged 














Approximate entropy (n = 19) Effect sizes (ES) 
 
Mean control ± SD control Mean COPD ± SD COPD Cohen’s ds Hedges’s gs 
1 0.1 1.9809 0.2087 1.8642 0.3494 -0.4056 -0.3971 
1 0.2 1.4038 0.2281 1.2954 0.3409 -0.3738 -0.3660 
1 0.3 1.0755 0.2123 0.9571 0.3181 -0.4377 -0.4285 
1 0.4 0.8400 0.1867 0.7543 0.2911 -0.3506 -0.3433 
1 0.5 0.6900 0.1657 0.6007 0.2538 -0.4165 -0.4077 
2 0.1 1.4006 0.0613 1.3100 0.0957 -1.1279 -1.1042 
2 0.2 1.2506 0.1813 1.1322 0.2325 -0.5677 -0.5558 
2 0.3 0.9934 0.1955 0.8686 0.2504 -0.5557 -0.5441 
2 0.4 0.7854 0.1771 0.6913 0.2355 -0.4514 -0.4420 
2 0.5 0.6469 0.1619 0.5496 0.2086 -0.5207 -0.5098 
3 0.1 0.5399 0.1486 0.5975 0.2248 0.3022● 0.2959● 
3 0.2 0.9635 0.0709 0.8899 0.1039 -0.8279 -0.8106 
3 0.3 0.8753 0.1347 0.7657 0.1864 -0.6734 -0.6593 
3 0.4 0.7217 0.1479 0.6275 0.1965 -0.5415 -0.5301 
3 0.5 0.6029 0.1453 0.5053 0.1821 -0.5925 -0.5801 
4 0.1 0.1275 0.0718 0.2069 0.1608 0.6375● 0.6241● 
4 0.2 0.5979 0.1426 0.6068 0.1364 0.0640● 0.0626● 
4 0.3 0.7145 0.0464 0.6467 0.1101 -0.8019 -0.7851 
4 0.4 0.6480 0.1051 0.5603 0.1437 -0.6962 -0.6816 
4 0.5 0.5556 0.1206 0.4643 0.1504 -0.6703 -0.6562 
5 0.1 0.0235 0.0206 0.0571 0.0609 0.7378● 0.7224● 
5 0.2 0.3082 0.1425 0.3583 0.1654 0.3249● 0.3181● 
5 0.3 0.5309 0.1000 0.4986 0.0845 -0.3486 -0.3413 
5 0.4 0.5680 0.0624 0.4863 0.0987 -0.9891 -0.9683 
5 0.5 0.5175 0.1012 0.4274 0.1262 -0.7870 -0.7705 
Table 1: Approximate entropy (ApEn) for controls and COPD subjects (both n = 19). Note: There were 1000 RR-intervals for each subject. Extra 
parameters are tolerance, r and, embedding dimension, M. There were 25 groups of values for tolerance, r (0.1→0.5 in intervals of 0.1) and 
embedding dimension, M (1→5 in intervals of 1). Established are the ApEn for the mean controls and their standard deviations, mean COPD and 
COPD standard deviations and their effect sizes (Cohen’s ds and Hedges’s gs) for control versus COPD. Where the effect sizes are positive (●) the 
statistical analysis is physiologically inappropriate. Where the values are in bold, these are the optimal values (in this range of M and r) for the two 
effect sizes Cohen’s ds and Hedges’s gs. 
 
Figure 1: Contours greyscale (above) and lines (below) for the approximate entropy (ApEn) for controls (n = 19) and subjects exhibiting symptoms 
of COPD (n = 19). Note: In the data there were 1000 RR-intervals throughout. Values for tolerance, r (0.01→0.25 in intervals of 0.01) and, 
embedding dimension, M (1→5 in intervals of 1). The ApEn for the controls (left), those with COPD (middle), the difference for ApEn between 
the controls and those with COPD (right). 






Figure 2: Effect sizes for controls versus COPD subjects (both n = 19). Note: 1000 RR-intervals were required in the calculations for each subject 
where, tolerance is r (0.01→0.25 in intervals of 0.01) and embedding dimension is M (1→5 in intervals of 1). The physiologically appropriate 
values for effect sizes are negative and so decreasing on the Cohen’s ds and Hedges’s gs axes. 
 
r 
Effect sizes by Cohen’s ds 
 
Effect sizes by Hedges’s gs 
M = 1 M = 2 M = 3 M = 4 M = 5 M = 1 M = 2 M = 3 M = 4 M = 5 
0.01 0.0608 0.6127 0.4934 0.4388 0.5079 0.0595 0.5999 0.4831 0.4296 0.4973 
0.02 -0.2093 0.4531 0.4423 0.4242 0.5079 -0.2049 0.4436 0.4330 0.4153 0.4973 
0.03 -0.4388 0.1128 0.2733 0.3886 0.3874 -0.4296 0.1105 0.2675 0.3804 0.3793 
0.04 -0.5610 -0.0932 0.3535 0.5558 0.6353 -0.5493 -0.0912 0.3461 0.5441 0.6220 
0.05 -0.6668 0.3584 0.7477 0.8502 0.9331 -0.6528 0.3508 0.7320 0.8324 0.9135 
0.06 -0.3805 -0.1017 0.3118 0.4976 0.4928 -0.3725 -0.0995 0.3052 0.4871 0.4825 
0.07 -0.3740 -0.1163 0.3154 0.3048 0.1513 -0.3661 -0.1139 0.3088 0.2984 0.1481 
0.08 -0.4447 -0.3213 0.4649 0.6151 0.5624 -0.4354 -0.3146 0.4552 0.6022 0.5506 
0.09 -0.3060 -0.5901 0.1888 0.3684 0.3866 -0.2995 -0.5777 0.1848 0.3606 0.3785 
0.10 -0.4056 -1.1279 0.3022 0.6375 0.7378 -0.3971 -1.1042 0.2959 0.6241 0.7224 
0.11 -0.5296 -0.9781 0.4275 0.7128 0.7627 -0.5185 -0.9576 0.4186 0.6978 0.7467 
0.12 -0.3796 -0.9528 0.0850 0.5090 0.6498 -0.3716 -0.9328 0.0832 0.4984 0.6362 
0.13 -0.4747 -0.8210 0.2058 0.6023 0.6913 -0.4647 -0.8037 0.2014 0.5897 0.6768 
0.14 -0.4458 -0.7488 0.1530 0.5294 0.6097 -0.4365 -0.7331 0.1498 0.5183 0.5969 
0.15 -0.4846 -0.7479 -0.1056 0.4630 0.7402 -0.4745 -0.7323 -0.1034 0.4533 0.7247 
0.16 -0.5012 -0.7591 -0.2145 0.4852 0.7228 -0.4907 -0.7432 -0.2100 0.4750 0.7077 
0.17 -0.3761 -0.6554 -0.4725 0.2739 0.5352 -0.3682 -0.6416 -0.4626 0.2681 0.5239 
0.18 -0.3808 -0.6159 -0.5381 0.1918 0.4626 -0.3728 -0.6030 -0.5268 0.1878 0.4529 
0.19 -0.5304 -0.7528 -0.7262 0.4196 0.6585 -0.5193 -0.7370 -0.7110 0.4108 0.6447 
0.20 -0.3738 -0.5677 -0.8279 0.0640 0.3249 -0.3660 -0.5558 -0.8106 0.0626 0.3181 
0.21 -0.4177 -0.5999 -0.7090 0.1806 0.3664 -0.4089 -0.5873 -0.6941 0.1769 0.3587 
0.22 -0.4614 -0.6397 -0.8887 -0.1110 0.3000 -0.4518 -0.6263 -0.8701 -0.1087 0.2937 
0.23 -0.5107 -0.6871 -0.8871 -0.1657 0.2948 -0.5000 -0.6727 -0.8685 -0.1622 0.2886 
0.24 -0.4816 -0.6638 -0.9227 -0.3305 0.1911 -0.4715 -0.6499 -0.9034 -0.3235 0.1870 
0.25 -0.4617 -0.6158 -0.8332 -0.5616 0.0653 -0.4520 -0.6029 -0.8157 -0.5499 0.0639 
Table 2: Effect sizes by Cohen’s ds and Hedges’s gs for controls versus COPD subjects (both n = 19). Exactly 1000 RR-intervals were required in 
the calculations for each subject. Extra parameters consist of tolerance, r and embedding dimension, M (1 →5). There were 25 values for tolerance, 
r (0.01→0.25, in intervals of 0.01). 
Discussion 
COPD has been established as a dynamical disease [2, 7, 8] which has been revealed to decrease the chaotic response 
and irregularities of the RR-intervals. This has previously been observed via chaotic global dimensions [2]. We then 
studied the responses of ApEn on the same dataset as in that chaotic global study [2] and when ApEn was 
systematically applied via 25 different parameters for tolerance, r (0.1→0.5 in intervals of 0.1) and embedding 





dimension, M (1→5 in intervals of 1); 20 out of 25 (80%) of these combinations were viable when considered 
physiologically. This was twice that over a similar analysis in subjects with type 1 diabetes mellitus (DM1) [28]. The 
COPD results signify that ApEn is capable of identifying the reduction in chaotic response and the best combination 
of r and M for this was 0.1 and 2, respectively. 
Chaos and other irregularities typically decrease in pathological states, as observed in this study in individuals with 
COPD. The amount of chaotic response through ApEn has several advantages. Firstly, it can be successfully applied 
to short time-series (RR < 50), and secondly, it can accurately respond notwithstanding substantial levels of signal 
noise. Despite this, its main drawback is the selection of optimum parameters for tolerance, r and embedding 
dimension, M. In this study, at the outset, we applied 25 different combinations of r and M (Table 1). Later, these 
were studied in finer detail (Table 2). Since COPD is a pathological dynamical disease which lessens the chaotic 
response of HRV; those combinations of r and M which increase their responses for COPD were disregarded and they 
are physiologically inappropriate. These achieve positive effect sizes for Cohen’s ds and Hedges’s gs. 5 out of 25 
(20%) of these permutations provided a higher value for the control than for the COPD subjects, so unsuitable. 
Inspecting the results (Table 1), we can observe that the optimum combination of M is 2 and r is 0.1. When we consider 
the values more closely regarding the tolerance, r and embedding dimension, M levels the optimal combination of r 
and M for this is again 0.1 and 2, respectively (Table 2 and Figure 2). This, once more calculates an effect size of         
-1.13 for Cohen’s ds, and -1.10 for Hedges’s gs. 
Thus, in this study, ApEn has been revealed to be a significant mathematical marker if the embedding dimension, M 
and tolerance, r are chosen such that the differences are maximized as measured by Cohen’s ds, and Hedges’s gs. 
There is at present no procedure or algorithm to systematically designate these values. Therefore, ApEn can be viewed 
as an erratic mathematical marker which can only be applied when the M and r are optimally selected by trial and 
error. 
Typically, when assessing HRV in studies using ApEn the fixed values are often set at M = 2 and r = 0.2 where this 
indicates 20% of the standard deviation of the time series [30]. Therefore, if we were enforcing ApEn in clinics or 
hospital units it would be too slow to calculate all the possible values of ApEn as in this study. It would necessitate 
implementation of multiple calculations each time to attain the specific value to evaluate a healthy or pathological 
condition. The optimum values here for COPD do not differ markedly to those in DM1 in the similar study [28], but 
the values which are physiologically accurate are more numerous in COPD. In light of these two studies on ApEn, 
with DM1 optimal r = 0.08 and M = 2 [28] and COPD r = 0.1 and M = 2, it is useful to re-evaluate if setting M = 2 
and r = 0.2 for all datasets is appropriate. A more sophisticated approach is likely required. 
Despite the advantages of ApEn, such as performing well on short time-series (RR < 50), even in the presence of 
signal noise; in this study ApEn has been established to be a relatively unpredictable mathematical marker. We 
encourage the use of other techniques, such as the chaotic global procedures [2, 13] and Katz fractal dimension [47, 
48], for assessing pathological states. The Katz fractal dimension metric necessitates cubic spline interpolation [46, 
47] therefore is also time expensive in circumstances where again processing speed is important. Chaotic globals are 
algorithmically simpler, perform well on relatively short time-series (RR > 256) [48], even with signal noise, 
discriminate between the groups better and need less computational time when the determination of optimal M and r 
is accounted for. This is imperative in situations where slow mathematical responses to physiological variables are 
unsuitable. 
Conclusion 
The ApEn was able to identify the reduction in chaotic response in COPD. The optimal combination of r and M for 
this were 0.1 and 2, respectively. Despite this, the ApEn has been established as an unpredictable mathematical marker 
requiring bespoke parameters if to be applied successfully and the use of other techniques to evaluate a healthy or 
pathological condition is encouraged. 
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